Figure 2f shows that cetuximab promoted little change in EGFR protein expression in all three cell lines but significantly reduced the expression of two p-EGFR (Y992 and Y1068) proteins in YD-38/CIS. The gene discussed is EGFR; the disease is in situ carcinoma.